Production (Stage)
Evolent Health, Inc.
EVH
$7.21
-$0.15-2.04%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.25% | 45.49% | 20.60% | -17.14% | -277.77% |
| Total Depreciation and Amortization | 35.82% | 42.34% | 7.76% | 33.89% | 112.76% |
| Total Amortization of Deferred Charges | -14.25% | -18.12% | -23.82% | -18.55% | 14.80% |
| Total Other Non-Cash Items | 14.48% | -14.41% | 34.67% | 137.07% | 369.74% |
| Change in Net Operating Assets | -506.76% | -632.42% | 41.53% | 128.27% | 150.65% |
| Cash from Operations | -88.15% | -86.84% | 51.16% | 607.60% | 310.04% |
| Capital Expenditure | -49.42% | -15.21% | -24.84% | 31.60% | 31.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -1,181.21% | 94.98% | 100.00% | 100.00% | 99.76% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -150.82% | -1,285.52% | -171.37% | -147.19% | -128.69% |
| Cash from Investing | -118.91% | 84.86% | 88.15% | 94.65% | 95.49% |
| Total Debt Issued | -28.53% | -90.95% | 52.87% | -17.73% | -17.83% |
| Total Debt Repaid | 85.49% | 100.00% | -778.38% | -1,039.28% | -1,039.28% |
| Issuance of Common Stock | -79.96% | -72.35% | -34.35% | 2.13% | 109.57% |
| Repurchase of Common Stock | 64.99% | -2.67% | -7.13% | -18.18% | -17.75% |
| Issuance of Preferred Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 3.15% | -6.87% | -49.96% | -139.05% | -453.82% |
| Other Financing Activities | -359.77% | 44.58% | -3,837.63% | -446.16% | 57.50% |
| Cash from Financing | 210.66% | -100.20% | -151.25% | -137.19% | -114.84% |
| Foreign Exchange rate Adjustments | -0.60% | -189.87% | -4.72% | 18.45% | 28.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.89% | -641.76% | -425.63% | 4.37% | 158.61% |